Podcasts about Toronto

Release Yourself Radio Show #1264Roger Sanchez In The Mix from Future, Toronto, CanadaTracklist currently unavailable*Please note this show may contain curse words and offensive language* Release Yourself with world renowned DJ, Producer, Radio and Podcast host Roger Sanchez. More Roger Sanchez on http://rogersanchez.com Hosted on Acast. See acast.com/privacy for more information.

Welcome to the 264th episode of the Meta Pod podcast, the #PokémonTCG podcast that revolves around the evolving meta! @AtrociousJake & @gyrosean sit down to talk about the latest #PlayPokemon & #Pokemon news!--We have a Discord server! Join here: https://discord.gg/5DhX4sbJu3--Reach out to us with any thoughts or topic suggestions viaTwitter: https://twitter.com/metapodtcg Instagram: https://www.instagram.com/metapodtcg/TikTok: https://www.tiktok.com/@metapodtcgCheck out the Meta Pod YouTube: https://www.youtube.com/channel/UCWcPqrzElSZKqYOIkMgOZuwFollow our Threads: https://www.threads.net/@metapodtcgSee the decks we showcase: https://pokemoncard.io/author/?author=54755-- Here are a few of the other places where we make content: Sean's YouTube: https://youtube.com/gyrosean Jake's YouTube: https://www.youtube.com/c/atrociousjake Sean's Twitch: https://www.twitch.tv/gyrosean Jake's Twitch: https://www.twitch.tv/atrociousjakeSean's Threads: https://www.threads.net/@gyroseanJake's Threads: https://www.threads.net/@atrociousjake

In this episode of Working Class Audio, Matt welcomes back Producer, Mixer & Mastering Engineer Justin Gray. Based in Toronto, Canada, Justin has worked on projects for Snoop Dogg, Brandy, Nicky Youre, Mother Mother, Arkells, Jamie Fine, Lola Brooke, Upsahl, and The Sheepdogs.In this conversation, Justin Gray discusses his album 'Immersed', exploring the creative process, technical aspects of immersive audio, and the importance of community and collaboration in music production. He shares insights on funding, marketing strategies, and the role of social media in promoting his work. The discussion also touches on the challenges of balancing family life with artistic pursuits and the significance of believing in oneself as an artist.In This Episode, We Discuss:Innovative immersive audioEarly surround experimentsCommunity-driven collaborationCanadian arts fundingValue of physical mediaSocial media promotionImpact of recognitionBalancing family supportBelief in the workEngineer and ArtistLinks and Show Notes:Justin's Site Links to all streaming PlatformsBand CampImmersive Audio AlbumJustin on WCA #451Matt's Rant: Forming Your Own BubbleCredits:Guest: Justin GrayHost/Engineer/Producer: Matt BoudreauWCA Theme Music: Cliff TruesdellThe Voice: Chuck Smith

From 'Play Tessie' (subscribe here): Gordo, Sammy, and Pat are all finally in the same time zone to discuss the shocking signing of Kazuma Okamoto to the Blue Jays. What does this do for Toronto and more importantly the Red Sox for the rest of the offseason? Then, even though they haven't made any signings, the Sox have added almost the same amount of players as the Jays, but one definitely feels better than the other. And, Alex Bregman seemingly has an "aggressive" offer from the Sox, but if that report is leaked from Boston's end then who knows how aggressive the offer really is. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Join Bryan Hayes and Jason Strudwick for Hour 1 on OverDrive! The guys discuss Brad Treliving's comments on his choice between the Panthers and Maple Leafs in free agency, the fans running Mitch Marner out of town and his baiting of the team in Toronto. MLB.com Blue Jays Reporter Keegan Matheson on Kazuma Okamoto's signing with the Blue Jays, his role on the roster and the team's offseason signings and Confirm or Deny going around the sports world.

Join Bryan Hayes and Jason Strudwick for Hour 2 on OverDrive! TSN Hockey Analyst Mike Johnson on Brad Marchand's comments on the Maple Leafs, Auston Matthews' season turnaround and Canada's bronze medal win against Finland. Maple Leafs Broadcaster Joe Bowen on Matthews' goal scoring record, his career in Toronto and playing through injuries on the roster and Bryan gives his FanDuel Best Bets.

Maple Leafs Broadcaster Joe Bowen joined OverDrive to discuss the headlines around the Maple Leafs and Panthers' matchup, Auston Matthews' goal scoring record and the career in Toronto, playing through the injury bug, the depth of the roster and more.

I'm Steve Dennis, strategic advisor, keynote speaker, bestselling author, and host of the industry leading Remarkable Retail podcast, along with fellow retail insider Michael LeBlanc.Discover why C-suite executives from Amazon, Walmart, Ikea, Tractor Supply, Vuori and dozens more - choose to share their growth stories on the only retail podcast hosted by two of the NRF's top voices for 2025 and 2026.With AI reshaping just about everything, when making sense of competing narratives has never been more challenging, and when so many brands face an existential choice between becoming remarkable or risking irrelevance, Michael and I are here to give you the no-BS perspectives you need to aim higher, move faster, and take the bold actions you must.Our new season debuts January 13th, 2026,  so be sure to follow the Remarkable Retail podcast on all the major platforms and on YouTube. SPECIAL OFFER for our listeners! SAVE 20% on registration for the all new Shoptalk Luxe event in Abu Dhabi January 27-29.For more info go to https://luxe.shoptalk.com/page/get-ticket and then register using our special code : RRLUXE20 About UsSteve Dennis is a strategic advisor and keynote speaker focused on growth and innovation, who has also been named one of the world's top retail influencers. He is the bestselling authro of two books: Leaders Leap: Transforming Your Company at the Speed of Disruption and Remarkable Retail: How To Win & Keep Customers in the Age of Disruption. Steve regularly shares his insights in his role as a Forbes senior retail contributor and on social media.Michael LeBlanc is the president and founder of M.E. LeBlanc & Company Inc, a senior retail advisor, keynote speaker and now, media entrepreneur. He has been on the front lines of retail industry change for his entire career. Michael has delivered keynotes, hosted fire-side discussions and participated worldwide in thought leadership panels, most recently on the main stage in Toronto at Retail Council of Canada's Retail Marketing conference with leaders from Walmart & Google. He brings 25+ years of brand/retail/marketing & eCommerce leadership experience with Levi's, Black & Decker, Hudson's Bay, CanWest Media, Pandora Jewellery, The Shopping Channel and Retail Council of Canada to his advisory, speaking and media practice.Michael produces and hosts a network of leading retail trade podcasts, including the award-winning No.1 independent retail industry podcast in America, Remarkable Retail with his partner, Dallas-based best-selling author Steve Dennis; Canada's top retail industry podcast The Voice of Retail and Canada's top food industry and one of the top Canadian-produced management independent podcasts in the country, The Food Professor with Dr. Sylvain Charlebois from Dalhousie University in Halifax.Rethink Retail has recognized Michael as one of the top global retail experts for the fourth year in a row, Thinkers 360 has named him on of the Top 50 global thought leaders in retail, RTIH has named him a top 100 global though leader in retail technology and Coresight Research has named Michael a Retail AI Influencer. If you are a BBQ fan, you can tune into Michael's cooking show, Last Request BBQ, on YouTube, Instagram, X and yes, TikTok.Michael is available for keynote presentations helping retailers, brands and retail industry insiders explaining the current state and future of the retail industry in North America and around the world.

Former NHL coach Dallas Eakins steps in for Ray, as he and Dregs tip their caps to the David Branch & Bob Pulford who both passed away over the weekend. Pulford, the Hall-of-Famer who was a four-time Cup champ with Toronto and veteran of 800-plus NHL games behind the bench, and Branch, the OHL Commissioner who genuinely cared about shaping players into better young men. Then, we discuss Sweden's huge gold medal win at the World Juniors and support for Team Canada despite their much-discussed semifinal loss to Czechia. Eakins feeling that Canada always gets every opponent’s best, so no Hockey Canada summit needed. Discussion on how the NHL's current parity keeps fans invested, practice versus visualization, and how MacKinnon, McDavid, and Celebrini's elite seasons have the game is in great hands with stars who make everyone around them better.See omnystudio.com/listener for privacy information.

Low Value Mail is a live call-in show discussing current events, politics, conspiracies and much more.Every Monday night at 7pm ETSupport The Show:

Craig Elsten, Chris Reed, and Raphie Cantor are back for the first pod of 2026 in which they cover the signing of Kazuma Okamoto in Toronto and what that says or doesn't say about the Padres, fringe roster guys, a look around the NL West and the upgrades of our rivals, before finally announcing the results of their patron poll in which PHT canon is enshrined and their alternate universe pods for the other 29 MLB teams is established.Want to get this show and tons of others early and ad-free? Plus access to our vaunted PHT Discord server and more? Become a patron at patreon.com/padreshottub

On this episode of A History of Christian Theology, Chad sits down with Dr. Stephen Chester to discuss his recently published book, Paul through the Eyes of the Reformers: Living under Grace (Eerdmans). Dr. Chester is the Lord and Lady Coggan Professor of New Testament at Wycliffe College in Toronto and is widely known for his influential work on the interpretation of Scripture—especially regarding Paul and the Reformers.Chad and Dr. Chester enjoy a thoughtful and engaging conversation about the New Perspective on Paul: what it is, what to make of it, and how we should understand the reformer's view of Paul. Many thanks to Dr. Chester for taking the time to join us. We hope you enjoy!Buy "Paul through the Eyes of the Reformers Living under Grace"Subscribe to our PatreonX: @theologyxianFacebook: https://www.facebook.com/ahistoryofchristiantheology

On today's show: - Mike McDaniel is still head coach of the Dolphins for now. How much input will he have in the hiring of a new GM?" - Lamar Jackson vs John Harbaugh: who would you want for the Fins? - Heat take on the Timberwolves in Minnesota on National TV tonight - Trae Young to the Heat? -- Panthers hit the ice tonight in Toronto to face the Maple Leafs - Matthew Tkachuck close to be back with the team - Hurricanes are in Glendale ready to face the Ole Miss Rebels on Thursday

In this episode, Tim and Mikey recap the Atlanta Hawks' 100-118 loss to the Toronto Raptors. Toronto dominated the points in the paint, 64-44, and the transition game, 29-16, to sweep the season series. Mikey and Tim also give their thoughts on the latest reporting surrounding the Trae Young trade situation. FOLLOW us on “X”: @EthosHawks @Tim_ATL @MRKHoops The FantasyPass isn't just for drafts anymore! Come enjoy DAN'S FANTASY ADDS/DROPS IN REAL TIME in our premium Discord… starting at just $6/month! Click to learn more! SUBSCRIBE, Rate and Review iTunes: https://tinyurl.com/ymf6vssp Spotify: https://tinyurl.com/yll6somy Join our Fantasy Sports Discord Server by clicking this sentence – https://discord.gg/jSwGWSHqaV Looking for the Bru and Besbris Secret Shows? The only way to get the URLs when they happen is to jump on the email list by heading here: https://landing.mailerlite.com/webforms/landing/g5c9a0 Manscaped is BACK, baby! Just like the NBA! Use coupon code HOOPBALL20 to get 20% off and free shipping on your purchase at Manscaped.com! Want more codes? We got 'em! ExpressVPN is offering 3 BONUS months on every 12-month membership purchase by using this special link: https://www.expressvpn.com/hoopball Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

As mass protests continue across Iran, Roqe launches IRAN RISES, a new twice-weekly series dedicated to understanding an uprising that is not simply about economic unrest – but about legitimacy, power, and regime change. This episode opens with Jian's short essay arguing that what is unfolding in Iran is a new revolution. What follows is a focused panel discussion examining the current phase of the uprising, insights coming directly from inside the country, the Islamic Republic's posture, and what the near future may realistically look like. Panel: Nazanin Ansari – Iranian journalist, editor (London) Kamyar Mahinsa – Police officer, analyst (Vancouver) Ali Fathollah-Nejad – Political scientist, Iran expert (Berlin) This edition of Roqe is brought to you with the support of: Stellar Law – a Toronto-based boutique litigation firm Visit stellarlaw.ca iWelcome – premium Iranian-Canadian tour, travel, and limo services Visit iwelcome.ca Hosted by Jian Ghomeshi. Meezoon basheen.

Over the weekend, the U.S. military entered Venezuela and captured its president, Nicolás Maduro, and his wife. Maduro will now face drug and gun charges in New York, and some members of the Trump administration have described the operation as a law enforcement mission.President Donald Trump has taken a different tack. He has justified the operation by asserting that America is going to “take over” Venezuela's oil reserves, even suggesting that oil companies might foot the bill for the broader occupation and rebuilding effort. Trump officials have told oil companies that the U.S. might not help them recover lost assets unless they fund the American effort now, according to Politico.Such a move seems openly imperialistic, ill-advised, and unethical — to say the least. But is it even possible? On this week's episode of Shift Key, Rob talks to Rory Johnston, a Toronto-based oil markets analyst and the founder of Commodity Context. They discuss the current status of the Venezuelan oil industry, what a rebuilding effort would cost, and whether a reopened Venezuelan oil industry could change U.S. energy politics — or even, as some fear, bring about a new age of cheap fossil fuels. Shift Key is hosted by Robinson Meyer, the founding executive editor of Heatmap, and Jesse Jenkins, a professor of energy systems engineering at Princeton University. Jesse is off this week.Mentioned: The 4 Things Standing Between the U.S. and Venezuela's OilTrump admin sends tough private message to oil companies on VenezuelaPreviously on Shift Key: The Trump Policy That Would Be Really Bad for Oil Companies--This episode of Shift Key is sponsored by …Heatmap Pro brings all of our research, reporting, and insights down to the local level. The software platform tracks all local opposition to clean energy and data centers, forecasts community sentiment, and guides data-driven engagement campaigns. Book a demo today to see the premier intelligence platform for project permitting and community engagement.Music for Shift Key is by Adam Kromelow. Hosted on Acast. See acast.com/privacy for more information.

Bills vs Jets Reactions | Breaking Tables:8pm, Team BT discusses yesterday's emotional victory! We are joined with long time season ticket holder, Dave Kaprosch from Hit the Showers!#BreakingTables #BillsMafia

Ailish Forfar and Justin Cuthbert kick things off following a busy weekend in sports, highlighted by the Jays landing Japanese star Kazuma Okamoto. Then, Sportsnet's Arden Zwelling joins the show (9:18) to discuss what the addition of Okamoto means for Toronto and their pursuit of Bo Bichette and/or Kyle Tucker, where Okamoto will fit in on the roster, how the World Baseball Classic will impact spring training, how the rest of the division has improved alongside Toronto, and much more. Later, Ailish and Justin discuss Canada's “early” exit at the World Juniors and then conduct a 'Who won't win the Super Bowl' draft!The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

Blake Murphy joins JD in-studio to get into any offseason Blue Jays thoughts he has, before switching gears to the Raptors. JD and Blake dive into their New Years resolutions for the Raptors, the pairing of Scottie Barnes and Brandon Ingram, and which depth players are a part of the team's long-term plan. The show ends with 'What we Missed'! (35:00)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.  

JD reacts to the Raptors' win over the Hawks last night, before bringing on The Athletic's James Mirtle. JD and James dive into their biggest Maple Leafs storylines halfway through the season (12:00),  along with the most disappointing and most underrated aspects at the midway mark. Finally, JD shares his letter grades for each Maple Leaf on the roster (40:00). The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates. 

After the US raid on Venezuela and arrest of its de facto leader Nicolas Maduro, Donald Trump warned a number of other countries that they could be next. Matt Galloway speaks to Janice Stein, founding director of the Munk School of Global Affairs & Public Policy at the University of Toronto and Jorge Heine, former Chilean cabinet minister and co-author of The Non-Aligned World: Striking Out in an Era of Great Power Competition.

Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic options across smoldering multiple myeloma, transplant eligible multiple myeloma, transplant ineligible multiple myeloma, and relapsed or refractory multiple myeloma. They highlight the importance of shared decision making and patient-centric care. They comment on the explosion of new treatment options in this space and the impetus for this guideline becoming a living guideline, which will be updated on an ongoing, regular basis. Read the full guideline, "Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline" at www.asco.org/hematologic-malignancies-guidelines. TRANSCRIPT This guideline, clinical tools and resources are available at www.asco.org/hematologic-malignancies-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology,  https://ascopubs.org/doi/10.1200/JCO-25-02587   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts. My name is Brittany Harvey, and today I am interviewing Dr. Lisa Hicks from St. Michael's Hospital and University of Toronto, and Dr. Joseph Mikhael from the Translational Genomics Research Institute, an affiliate of City of Hope Cancer Center, co-chairs on "Treatment of Multiple Myeloma: American Society of Clinical Oncology-Ontario Health (Cancer Care Ontario) Living Guideline." Thank you for being here today, Dr. Hicks and Dr. Mikhael. Dr. Lisa Hicks: Thanks so much. Dr. Joseph Mikhael: It is a pleasure to be with you, Brittany. Thank you. Brittany Harvey: Before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Hicks and Dr. Mikhael who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then to dive into what we are here today to talk about, Dr. Mikhael, I would like to start by recognizing that this guideline updates the 2019 ASCO-CCO Guideline on the Treatment of Multiple Myeloma. So what prompted this update and what is the scope of this updated guideline? Dr. Joseph Mikhael: It is amazing when we think back in myeloma years, 2019 actually seems a very, very long time ago because really so much has changed in myeloma over these last six to seven years. Indeed, there have been over 150 randomized controlled trials that we didn't have at the prior guideline that we reviewed for this. Myeloma is a disease that has really changed so dramatically over these last several years. Multiple new agents have been introduced. We now have CAR-T cell therapy, bispecific antibodies, and multiple other agents that were not available at the time. Furthermore, with this growing complexity, it is becoming more important than ever to be able to provide practical advice and guidelines to the oncology community. For most oncologists, they have less than 5% of their time dedicated to multiple myeloma. It is important to bring a clarity to them that allows them to care for their patients. And the scope of these guidelines, furthermore, really cover the whole spectrum of myeloma. They go further than our prior guideline where now we have included smoldering multiple myeloma along with frontline therapy and relapsed multiple myeloma. So, we have really tried to provide the full spectrum to our colleagues in oncology to ensure that they have the tools they need to provide the best care possible for their patients. Dr. Lisa Hicks: That is a really terrific summary. And maybe one thing I will just add is it is really unique to have this much literature. I can't think of another guideline that I have ever been involved with that has seen a field move so quickly and develop so many advancements in a period of just over four or five years. Brittany Harvey: Certainly, there is a large volume of evidence that you all had to review for this guideline update. I think to your point probably one of the greater volumes of literature for a guideline update that you both mentioned. Based on that, I would like to review the key recommendations that are updated in this guideline. So Dr. Hicks, that new patient population that Dr. Mikhael mentioned earlier, what are the key recommendations for patients with smoldering multiple myeloma? Dr. Lisa Hicks: So this is the first time that an ASCO guideline is addressing this branch of multiple myeloma care. It is an area where I think some guidance is needed, and smoldering myeloma is not an active cancer. And so one thing that I really want to highlight is that the panel felt very strongly that to recommend any therapy in this space we needed a higher level of evidentiary certainty, of evidentiary confidence, to make recommendations for active therapy. The panel really made two very important recommendations. First of all, the panel did not recommend treatment for low or intermediate risk smoldering myeloma. That is important. And then the area where I think for the first time we have recommended consideration of treatment is patients with high risk smoldering myeloma. And for patients with high risk smoldering myeloma, the panel recommended that it was appropriate to consider either treatment with daratumumab or careful observation. Dr. Joseph Mikhael: And I think that move forward as you have mentioned, Dr. Hicks, is particularly important because it is an area to some degree still of equipoise and many trials are going on in the area. But we do now have a strong phase III trial that supports the use of daratumumab monotherapy for three years when compared to close observation. But of course, that is not for everyone. And one of the key themes of all of our recommendations are going to be now that more and more choices are available, that we have discussions with our patients to ensure that we match the right treatment with the preference of the patient. And I think that is particularly important here in smoldering myeloma. Dr. Lisa Hicks: Multiple myeloma care and the multiple myeloma evidence is really so nuanced, and one of the nuances that readers will appreciate if they read the guideline is that how smoldering myeloma is risk stratified has been different across different trials. And that really adds to the complexity of this recommendation and is one of the reasons that the panel felt that it was appropriate to recommend either observation or treatment. Brittany Harvey: It is great to have these new recommendations for this unique patient population. And as you both mentioned, that individualized patient care is really important across this entire guideline. So then following those recommendations, Dr. Mikhael, what is recommended for initial therapy, autologous stem cell transplantation, post transplant therapy, and measurement of response for patients with transplant eligible multiple myeloma? Dr. Joseph Mikhael: Well, that is an area that has really considerably also grown since the last guideline. Obviously one would have to consult the guidelines to get every last detail, but in essence, we want to assess whether or not patients are transplant eligible or ineligible. And that assessment is not based on age or renal function alone, but indeed on a careful assessment of that patient. When that assessment is made and deemed that a patient is transplant eligible, our recommendation is that a patient typically would receive a quadruplet. That is to say, a monoclonal antibody directed against CD38, a proteasome inhibitor, an immunomodulatory drug, and dexamethasone to be given for approximately four to six cycles followed by the stem cell transplant, followed by potentially another two cycles of consolidation, and then maintenance therapy. A couple of important caveats. One, we do have two different CD38 antibodies that can be used, either daratumumab or isatuximab. Although typically bortezomib is the preferred proteasome inhibitor, consideration can be given to carfilzomib by virtue of the potential toxicity from bortezomib. And then lastly in the maintenance setting, we are typically recommending at least lenalidomide alone, but consideration can be given to dual maintenance therapy as the data is emerging to either add to that daratumumab or carfilzomib. All the while using the IMWG criteria for response. The goal of course is to achieve the deepest response possible and to maintain that response until such time as patients would relapse. Finally, the length of maintenance therapy continues to be an area of equipoise and study in multiple myeloma. And so at minimum, patients would receive two to three years of maintenance therapy, and based on risk status and depth of response it can be considered that patients would potentially come off maintenance therapy, of course always with the caveat that toxicity would influence length of therapy as well. Brittany Harvey: Yes, as you mentioned, evaluating which patients are eligible is extremely important for considering what is recommended in the guideline for both transplant eligible and transplant ineligible patients. So then Dr. Hicks, following those recommendations for transplant eligible multiple myeloma, what are the recommended treatments, goals of therapy, and measurement of response for patients with transplant ineligible multiple myeloma? Dr. Lisa Hicks: You know, I really can't emphasize enough how important an individualized patient assessment is. When we are thinking about the range of patients that are included in this category of transplant ineligible patients, it is a huge range. You may have fairly fit patients in their late 70s all the way to patients in their 90s. And we really want to see that treatments are tailored both to the fitness of the patient, their individual circumstances, and their preferences. And it is a wonderful thing to have lots of options for patients in this circumstance. What the guidelines have recommended for most patients who are transplant ineligible but fit enough for a stronger therapy is quadruplet therapy. So actually therapy that is very similar to what is being recommended in the transplant eligible population but for a longer period of time. And then for those patients who for whatever reason, be it their fitness or their preference, are not appropriate for that quadruplet therapy, the recommendation is for triplet therapy with a combination of lenalidomide, bortezomib, dexamethasone, or very often, more often in most cases, an antibody based approach with an anti-CD38 plus lenalidomide plus dexamethasone. Dr. Joseph Mikhael: The only thing I would add to that, I think we have to also, as we do mention in our recommendations, be particularly cautious with the dosing of these medications. Because even though we think of them as a single agent or a particular class, there can be quite a variation within the dosing regimen that can affect a patient's side effects and their quality of life. And so being very careful with dose modifications, and particularly in the transplant ineligible patient, is an important part of the recommendation as well. Dr. Lisa Hicks: Yeah, this is a podcast so no one can see me nodding vigorously that dose modification is so important particularly with those older and frailer patients, and with particular attention to trying to reduce dexamethasone doses and favoring weekly administration of bortezomib when that drug is used. Brittany Harvey: Absolutely. Considering the risks and benefits and patient preferences is really key to selecting therapy for these patients. So then Dr. Mikhael, for the final overarching patient population addressed in this guideline, for patients with relapsed or refractory multiple myeloma, what treatment options are recommended? Dr. Joseph Mikhael: This of course is, if you will, the biggest part of the guideline because there has been so much done in the relapse setting. And I think we start the guideline by saying a decision has to be made as to when to institute therapy. That there may be some patients with slow biochemical relapse that may be monitored for a period of time. But when the decision is made to initiate treatment, instead of a simple algorithm, the guideline emphasizes the fact that there are multiple choices that can be given to a patient that are going to match what comorbidities the patient has, what they have been treated with before, and of course what their preferences are. I think we highlight two particular areas. That now that CAR-T cell therapy is available as early as first relapse, it should be a consideration by virtue of the fact that it has resulted in such deep and durable responses. But that triplets should also be considered in that earlier relapse setting because we do have multiple classes of agents that can be used. We know that in later relapse options exist including bispecific antibodies for which we have four different choices. And that in general, patients will ultimately receive either a triplet or CAR-T cell therapy in earlier relapse, but there are some patients who may be eligible only for a doublet by virtue of their comorbidities and of their prior therapies. Lastly, it really does emphasize the point as we have mentioned a few times in this podcast, and I am so glad it keeps coming up, is that as I often say we don't treat myeloma, we treat people. And engaging the patient in that conversation to ensure that the right treatment gets matched to the right patients is particularly important because with all the new classes that we have with antibody drug conjugates, with XPO1 inhibitors, the traditional three classes of proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, along with as we have already mentioned CAR-T and bispecific antibodies, it really is an incredible laundry list of choice. And making that choice specific to the patient becomes absolutely critical. I should also lastly note that there are patients who may defer their initial transplant. There may be patients who may be eligible for a second transplant. So autologous stem cell transplant, although primarily used in the frontline setting, may still be a consideration for a smaller subset of patients in the relapse setting. Dr. Lisa Hicks: I think maybe one thing that I would add is an overarching principle which is actually similar to a principle in the first guideline, and that is that in the relapsed or refractory setting, there are many different treatment options. And in fact, the number of treatment options feels like it is evolving every day. But an overarching principle for clinicians to consider is to try and choose combinations of drugs that the patient has either not been exposed to in the past or certainly that they are not refractory to. We really want to be pulling new options out of the toolbox as much as we can. Dr. Joseph Mikhael: Very often we do see where someone may be on a triplet and they are progressing on it and someone just changes out one drug. We have suggested not to take that approach but to take the approach of completely introducing a new therapy when someone is progressing on their current therapy. I think that point is particularly important and the consensus panel was very clear. Brittany Harvey: Understood. That is very helpful when thinking about what options to offer to patients in the relapsed and refractory setting. And as you mentioned earlier, the figures in this guideline provide an outline of options and then the tables really go into some of the details and outcomes of the trials, and those are very helpful for clinicians to refer to. So then Dr. Hicks, we have talked a little bit about some of the nuances of the guideline, but what should clinicians know as they implement these new and updated recommendations? Dr. Lisa Hicks: I think they should feel comfortable that these are trustworthy guidelines. So these are evidence-based guidelines that have been rigorously developed after a very thorough evidence review and put together by a panel of experts who were extremely thoughtful in their review of the evidence. And so all of this contributes to the trustworthiness of the guidance. And then I would also encourage people to take a deep look at the guidelines because of the importance of nuance that is addressed in them, and then to also explore some of the tools that ASCO is developing that helps with implementation including the flow charts that are contained within the guidelines and some additional tools that are available online. Brittany Harvey: Absolutely. The tools and resources for this guideline are available online with the publication and we will provide links to that in the show notes of the episode. So then following that, Dr. Mikhael, how does this guideline update affect patients with multiple myeloma? Dr. Joseph Mikhael: As we sort of intimated earlier, I like to say I don't treat myeloma, I treat people. I think we should always be patient-centric and patient-focused. And I think in the discussion we always were. We always wanted to ensure that multiple factors go into a decision-making process. We are not just looking at the biology of the disease, we are looking at patient factors. Those patient factors include their frailty as we commented in a frailty assessment, their preferences, their comorbidities. And I think, in a day where we have so many choices, we emphasize in the guideline the importance of that conversation with the patient. That, if you will, shared decision-making model where options are laid out and based on the patient factors and the treatment factors they can then be meshed together in the best way so that patients can make the right choice. And of course in conjunction with the guidelines, we have patient friendly summaries of them. And we involved, of course, patients in the development of these guidelines. And I think that is one of the greatest strengths of the ASCO guidelines is that there is a patient with us at the table who is giving their perspective on the guideline as we go forward. So I am very thankful that we have created a product that is, if you will, not only for the providers, the practitioners that are prescribing these agents and that are directly giving the care, but indeed for the very patients who of course have the most at stake here. Dr. Lisa Hicks: Yeah Joe, I am so glad you called out the participation of patient partners in the guideline. It is such an important part and they were really- the patient partner was such an important part of this panel in helping us understand the patient perspective as we developed this guidance. Brittany Harvey: Definitely. It is a hugely important role for the panel and for all of the panel including the patient partners and the experts in the disease to review the evidence and come up with comprehensive recommendations. And yes, as you mentioned, the individualized treatment and the shared decision-making is really paramount to this guideline. Finally, Dr. Hicks, you alluded to earlier the vast number of treatment options that is really exploding in multiple myeloma. And so this guideline is becoming a living guideline continuously updated by ASCO. So what are the outstanding questions regarding this topic and what evidence is the panel looking forward to for future updates? Dr. Lisa Hicks: I am really excited about this. This is one of the first guidelines that will be a living guideline for ASCO and it is such a good fit. You have heard Joe and I say a few times how quickly this field is moving, how complex the field is. I think everyone on the panel knew that no matter how quickly we did it and how deeply we reviewed the evidence, it was inevitable that more evidence would be generated as we were putting out the guideline. In a field like that, it is really important that we find a way to provide evidence-based guidelines quickly to the community. You know, waiting another five years, letting another 150 trials accrue before we do another guideline is not what the community needs. And so ASCO has really risen to this challenge and is committed to living guidelines. And so a living guideline is a guideline that commits to reviewing the evolving evidence on an ongoing basis, watching for practice changing trials, and having a standing panel that will review evidence and update recommendations on a regularly scheduled basis. So that is what a living guideline is, and that is what this guideline is becoming. That is just the first thing in terms of what a living guideline is. And then what are we watching? Well, honestly what aren't we watching? There is so much happening in multiple myeloma. We knew as we put the guideline out that there were trials in process, some trials that had been released at conferences but not yet published. We will be waiting for those and if they are practice changing they will be addressed in upcoming updates. There is new evidence just recently presented around combined anti-CD38 and bispecific antibodies. I don't know yet whether that will be addressed but I wouldn't be surprised if it was. There are so many things coming down the pipeline and it is just wonderful that there is going to be a way to try and address them in a robust fashion. Dr. Joseph Mikhael: Yeah I agree with you, Lisa. I can't think of another disease that would be more relevant for a living guideline. I mean we had difficulty because new data kept coming in as we were making recommendations. And so at some point we had to draw a line and say this is where we will stop and produce this guideline and have it ongoing. And I really look forward to seeing the updates because we know as you mentioned that there are so many things that are on the verge of approval and on the verge of changing the way we manage this terrible disease. And before I close, I would love to remind all of our listeners that as we commented from the start, patient engagement is critical at ASCO and in our guidelines process. Unfortunately we lost a very dear patient during the guidelines process, and that is Jack Aiello. Jack Aiello had been a patient and a patient advocate for many, many years in the myeloma community. And indeed we have actually dedicated these guidelines to his honor. And so I thought it would be valuable for us to mention that today. And we miss you Jack, but we are very grateful that we have been able to dedicate this excellent body of work to your memory. Brittany Harvey: Absolutely. This guideline and your dedication to him is an honor to his memory and we really recognize him in thinking about this guideline. We will look forward to those future trial results that you mentioned, Dr. Hicks, to update this guideline and continue to provide options for patients with multiple myeloma and improve upon those options and shared decision-making with patients. So I want to thank you both for all of your work to develop this guideline and for your time today, Dr. Hicks and Dr. Mikhael. Dr. Lisa Hicks: You are so welcome. Thanks for featuring this guideline. Dr. Joseph Mikhael: Thank you so much, Brittany. It has been a privilege. Brittany Harvey: Finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/hematologic-malignancies-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines App, which is available in the  Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Toronto filmmaker Alan Zweig has his own show these days, and in honor of Tubby being named one of Apple and Amazon's Podcasts of 2025, here's his episode on Peter Yates' masterful 1973 crime drama The Friends of Eddie Coyle, starring Robert Mitchum as a low-level Boston mobster contemplating flipping on his associates to avoid a jail sentence. Jeez, your genial host Norm Wilner sounded so much younger in 2015 …

Toronto's melodic punk lifers Wasting Time are back with their new single “Ripped Blue Jeans”, out December 12 via People of Punk Rock Records. It's a nostalgic rush of anthemic hooks and heart-on-sleeve energy that could've soundtracked any MTV's 120 Minutes marathon. The track captures that feeling of late 90s freedom, cracked sidewalks, stickered guitars, the smell of sweat and stale beer in community-hall venues, and long summer nights when the world still felt small enough to dream your way out of it. Formed in 2017, Wasting Time has steadily built a catalog rooted in melody and sincerity: five EPs, three full-length albums, and a streak of singles that echo the honesty and grit of Alkaline Trio, No Use for a Name, MxPx, Blink-182, and Green Day. Their latest release, Hurry Up and Wait, cemented their reputation as one of Canada's most reliable carriers of melodic punk tradition, and “Ripped Blue Jeans” only deepens that lineage. Mixed and mastered by Matt Gauthier at Arc Studios, the single offers the first taste of their upcoming full-length, Are You Out Of Your God Damn Mind?, due out in the new year. The song hums with the spirit of a simpler time, before algorithms and playlists, when discovery meant burning mix CDs or catching a new band between Tony Hawk Pro Skater soundtracks. You can almost see the baggy Dickies, chain wallets, and flannel shirts tied at the waist. It's a nod to every kid who ever scribbled lyrics in the margins of a school binder or fell asleep to Dookie playing on repeat. Wasting Time capture that pulse without imitation; it's not nostalgia for its own sake, but a reminder of why those songs mattered in the first place. Wasting Time Online INSTAGRAM | SPOTIFY | BANDCAMP | FACEBOOK | X | YOUTUBE | TIKTOK Checkout my YouTube Channel with long form interviews from the Subversives | the History of Lowest of the Low. https://www.youtube.com/playlist?list=PL9d1VSeOHYuxFWKuRdmn9j8UTW6AHwS_fAlso my Weekly Tour Vlog is up an live on the YouTubeshttps://www.youtube.com/playlist?list=PL9d1VSeOHYuwphwhc4zd0VgY66f1OUQZp Pledge monthly with Patreon https://www.patreon.com/apologueShop Apologue products at http://apologue.ca/shopCheck out new Four Square Here: https://distrokid.com/hyperfollow/foursquare/brighton-beach-ephttps://distrokid.com/hyperfollow/foursquare/seven-oh-sevenhttps://distrokid.com/hyperfollow/foursquare/industry-at-home–21st-anniversary-remix-remasteredhttps://distrokid.com/hyperfollow/foursquare/when-weeks-were-weekends

This special episode comes directly from an inspiring day at the Royal Conservatory of Music (RCM) in Toronto, where the global launch of the Smart Start program was celebrated through a landmark symposium titled Music and the Mind: A Smart Start to Early Childhood Education. The event focused on the transformative role of music in early childhood learning and development. Educators, researchers, policymakers, and arts advocates gathered in Koerner Hall in Toronto to explore how music influences the developing brain, supports emotional and social growth, and enhances early learning well beyond songs and rhythm. The symposium also examined the evolving role of technology and artificial intelligence in education and creativity. Smart Start is the Royal Conservatory of Music's early childhood music program, designed for young learners at the very beginning of their musical journey. Grounded in research on child development and learning science, the program uses play-based, developmentally appropriate activities to nurture musical skills alongside cognitive, social, and emotional growth. Smart Start is about more than learning music—it supports whole-child development through music. For more background on how the program was developed, listen to the previous episode featuring Alexander Brose, President & CEO of The Royal Conservatory of Music: https://www.theartandscienceoflearning.com/blogsidebysidee/124-music-amp-neuroscience-the-royal-conservatory-of-musics-innovative-approach-to-early-childhood-education-alexander-brose The day opened with a powerful keynote from Renée Fleming, celebrated soprano and author of Music and Mind, who spoke about the impact of music and music therapy on health and wellbeing. She invited the audience to sing together in harmony—setting the tone for a day centered on connection, research, and shared experience. Alexander Brose, President & CEO of The Royal Conservatory of Music, welcomed attendees and shared the story behind Smart Start's creation and development. Throughout the day, internationally recognized voices from across disciplines contributed to panels and discussions on music, neuroscience, education, creativity, and innovation. Speakers and panelists included Evan Solomon, Canada's Minister of Artificial Intelligence, Raffi, the beloved children's singer-songwriter, Steve Paikin, the award-winning journalist, Eric Radford, Olympic figure skater and composer, and many more. The symposium also featured hands-on learning experiences led by Catherine West, pedagogy leader and early childhood education specialist, allowing participants to experience Smart Start exactly as children would in a learning environment. This episode brings the symposium to life through three in-depth interviews with key speakers: • Dr. Indre Viskontas – Associate Professor of Psychology at the University of San Francisco, musician, and host of the Inquiring Minds podcast, discussing the neuroscience of music and learning • Kevin Chan – Senior Director at META, exploring the connections between creativity, technology, AI, and education • Dr. Sean Hutchins – Director of Research at The Royal Conservatory of Music and co-developer of the Smart Start curriculum, unpacking the research and educational thinking behind the program Together, these conversations offer a rich picture of why Smart Start matters and how early, play-based music education can help develop cognitive skills, emotional regulation, creativity, and problem-solving abilities, setting children up to become lifelong learners. Dive in to revisit the ideas, insights, and inspiration from the Music and the Mind symposium, celebrating the global launch of the Royal Conservatory of Music's Smart Start program. Links: Royal Conservatory of Music (RCM) Neuroscience: https://www.rcmusic.com/about-us/rcm-neuroscience Music and the Mind Symposium (October 31st 2025): https://www.rcmusic.com/about-us/news/global-launch-of-rcm-early-childhood-music

Send us a textHow could one be a man of God in Nazi Germany?  And, especially, how can one minister to the Wehrmacht, itself an instrument of the Nazi state while professing to adhere to Christian morality?  These are the questions that Doris Bergen deals with in her book on German military chaplains.In this episode, we talk about the Nazi relationship with churches in Germany as well as about the ways in which German military chaplains became complicit in the crimes of the Third Reich. Doris Bergen is Chancellor Rose and Ray Wolfe Chair in Holocaust Studies at the University of Toronto.Bergen, Doris. Between God and Hitler: Military Chaplains in Nazi Germany (2025)Follow on Twitter @holocaustpod.Email the podcast at holocausthistorypod@gmail.comThe Holocaust History Podcast homepage is hereYou can find a complete reading list with books by our guests and also their suggestions here.

We're back with another AFTN Soccer Show packed full of Vancouver Whitecaps, Vancouver FC, and World Cup 2026 chat and interviews in our first podcast of 2026. A new year, new hopes, new dreams, but the same fantastic podcast content! The Whitecaps finished last year and started this one with a couple of big stories. Another player has moved on, with winger Ali Ahmed being sold to English Championship side Norwich City. Certainly not the sale of the century, we look at the transfer and what it means to both the 'Caps and to Ali. Plus we delve into the announcement that the Whitecaps have agreed a proposed settlement to a class action lawsuit around Messi's no-show in the Vancouver in 2024. Talking of court cases, we also look at former Vancouver FC head coach Afshin Ghotbi suing the club's owners SixFive Sports and Entertainment, plus we look at how Zach is feeling about the side as they head into the new year, both on and off the pitch. It's an exciting World Cup year, even more so with both Canada and Scotland being in the tournament and Vancouver and Toronto hosting matches. We've a lot of World Cup 2026 chat in this episode as Vancouver organizing committee lead Jessie Adcock talks about Vancouver's preparedness for welcoming the world to the city for the tournament and gives us some details on the Fanfest. Plus BC Place GM Chris May talks about the stadium's renovations to get ready to host matches and we look at who we think should be in Canada's starting XI come their first match in June. All of this plus we talk New Year hopes and predictions, kick off our Canadian Soccer A to Z series, and music-wise, Television Personalities begin their residency as our Artists of the Month with a couple of songs, we start our 40th anniversary tribute year to the C86 movement, and we have the first of many World Cup songs this year in Wavelength. Here's the rundown for the main segments from the episode: 01.46: Intro - New Year hopes and predictions, mailbag 25.26: Canadian Soccer A to Z - A 34.29: Who's in your CanMNT starting XI heading into the World Cup 56.34: Jessie Adcock on Vancouver's preparations to host the World Cup 78.14: Vancouver's World Cup Fanfest will be free to attend 85.16 Chris May on getting BC Place ready for the World Cup 96.54: Whitecaps settle ridiculous class action lawsuit 107.09 Ali Ahmed sold to Norwich City 126.24: C86 40th anniversary 134.34: Afshin Ghotbi take SixFive Sports & Entertainment to court 157.47: How Vancouver FC are looking heading into 2026 166.35: Wavelength - Del Amitri - Don't Come Home Too Soon

Ben Ennis and Brent Gunning open Tuesday's show by recapping the Raptors' 118-100 win over the Hawks. They break down the team's uneven effort of late, Collin Murray-Boyles' rookie impact, RJ Barrett's lineup fit when healthy, and some broader roster dynamics in Jakob Poeltl's absence. They also discuss concerns around Immanuel Quickley, the point guard rotation, and reports that Atlanta may move on from Trae Young. What's his value around the NBA? Are the Raptors interested? After the break, they shift to the Blue Jays and react to Jim Bowden's report on the interest in Bo Bichette and Kyle Tucker. Ben and Brent also get into the impact of signing Kazuma Okamoto, how the Jays infield could align, and which addition makes the most sense for the current roster.The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

Ben Ennis and Brent Gunning wrap up Tuesday by chatting with NHL insider Frank Servalli. They discuss the Leafs' blue line amid injuries, potential trade activity, and Auston Matthews' recent performance and any rumours about his happiness in Toronto. They also touch on the World Junior Hockey Championship and Gavin McKenna's draft prospects. After the break, Maple Leafs Hot Stove contributor Anthony Petrielli (26:09) joins to analyze the Leafs' recent play, the sustainability of their performance, and the D-core with Brandon Carlo's return. They consider Matthews' future form, Max Domi's struggles, and the improved power play under Steve Sullivan versus Marc Savard.The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliate.

Ben Ennis and Brent Gunning open the morning by previewing tonight's Maple Leafs-Panthers matchup. They focus in on the expectations for Toronto, the state of the blue line with Brandon Carlo returning and Jake McCabe out, recent play from Morgan Rielly, concerns around William Nylander's LTIR stint, and what kind of statement game this could be for Auston Matthews. The guys also touch on Canada's bronze medal finish at the World Junior Championship. After the break, Sportsnet's Michael Grange (29:00) joins the show to break down the last night's Raptors win over the Hawks. He dives into the impressive impact of rookie Collin Murray-Boyles, how the team is coping without Jakob Poeltl, concerns around Immanuel Quickley's play, and if the Raptors should consider a move for Trae Young if he becomes available.The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

Episode 400: In October 1894, 18-year-old Frank Westwood was shot on the doorstep of his Parkdale home. The killing shocked Toronto and sparked a frantic search for a suspect. Weeks later, a mixed-race tailor named Clara Ford walked into a Toronto police station and was quickly accused of the murder. With no weapon, no motive, and a disputed confession, her trial exposed deep racial bias and divided the city. This episode looks at Clara's life, the investigation that targeted her, and the aftermath of the trial that captivated Canada's largest city. Episode Sources:Clara at the Door with a Revolver — Carolyn Whitzman (UBC Press, 2023)Toronto Public Library – Digitized Toronto newspapersNewspapers.com – Historical Toronto press coverageCity of Toronto ArchivesArchives of Ontario – Mercer Reformatory & judicial recordsRace on Trial: Black Defendants in Ontario's Criminal Courts, 1858–1958 — Barrington WalkerAfua Cooper – Black Canadian history resourcesDEWART, HERBERT HARTLEY – Dictionary of Canadian BiographyJOHNSTON, EBENEZER FORSYTH BLACKIE – Dictionary of Canadian BiographyDeath in the Queen City: Clara Ford on Trial, 1895 By Parick BrodeA blood-drinking monster? When this Toronto woman was accused of murder, the newspapers of 1894 went wildA sensational Toronto murder from 1894 – Bill Gladstone GenealogyTranscript: The Story of a Black Woman Accused of Murder in 1894 | Feb 15, 2023 | TVO TodayInterview: Carolyn Whitzman on the archival story behind novel Clara at the Door  – MOBA Learn more about your ad choices. Visit megaphone.fm/adchoices

My conversation with Bill starts at 29 mins and Dean and I start at 1:05 Subscribe and Watch Interviews LIVE : On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous soul Bill Boyle is a well sourced and connected businessman who lives in Washington DC with his wife and son. Bill is a trusted friend and source for me who I met after he listened and became a regular and highly respected caller of my siriusxm radio show. Bill is a voracious reader and listeners love to hear his take. I think his analysis is as sharp as anyone you will hear on radio or TV and he has well placed friends across the federal government who are always talking to him. As far as I can tell he is not in the CIA. Follow him on Blue Sky and park at his garages. Dean Blundell is a Canadian radio legend. Follow Dean On Substack Best known as a longtime morning host on CFNY-FM (The Edge) in Toronto, Ontario. In 2015 he was named the new morning host of sports radio station CJCL (Sportsnet 590 The Fan). Dean started his career in radio in 2001 and for nearly 20 years has been entertaining radio audiences. Dean's newest venture is the launch of Crier Media and his podcast "The Dean Blundell Show" which is gaining tremendous momentum across North America. On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page

We talk with journalist Lana Hall about her piece The Dead Mall Society, which details her journey to decaying malls in the Toronto area in search of Liminal Spaces.Liminality (Wikipedia)Victor Turner: Liminality and Communitas (PDF)The Liminality Project (blog)Liminal Space (Wikipedia)The Backrooms CreepyPasta (Wikipedia)Become a supporter of this podcast: https://www.spreaker.com/podcast/monstertalk--6267523/support.Some product links may be affiliated with Amazon revenue sharing.

Full set here: https://podcasts.apple.com/us/podcast/richie-hawtin-dj-mix-set-from-church-rave-in-toronto/id1570311853?i=1000743877181 Subscribe to listen to Techno music DJ Mix, Tech House music, Deep House, Acid Techno, and Minimal Techno.

Join Bryan Hayes and Jamie McLennan for Hour 1 on OverDrive! The guys discuss Canada's defeat in the semifinal and the downfall against Czechia, Auston Matthews achieving the Maple Leafs' all-time goals record and his performance through the season, Matthew Schaefer's impressive season with the Islanders and Morgan Rielly's concerns on the blue line. O-Dog joins to dive into Canada playing for a bronze medal, Czechia's significant win and Matthews' goal record in Toronto.

Welcome to the Social-Engineer Podcast: The Doctor Is In Series – where we will discuss understandings and developments in the field of psychology.   In today's episode, Chris and Dr. Abbie explore psychopathy, focusing on its clinical definition and common misconceptions. They discuss how the term is often misapplied to various behaviors, stressing the importance of understanding its roots in empathy and fear. By highlighting the need for accurate knowledge, they aim to prevent stigmatization and promote a deeper understanding of mental health. [Jan 5, 2026]     00:00 - Intro 00:24 - Dr. Abbie Maroño Intro 00:42 - Intro Links -          Social-Engineer.com - http://www.social-engineer.com/ -          Offensive Security Vishing Services - https://www.social-engineer.com/offensive-security/vishing/ -          Offensive Security SMiShing Services - https://www.social-engineer.com/offensive-security/smishing/ -          Offensive Security Phishing Services - https://www.social-engineer.com/offensive-security/smishing/ -          Call Back Phishing - https://www.social-engineer.com/offensive-security/call-back-phishing/ -          Adversarial Simulation Services - https://www.social-engineer.com/offensive-security/adversarial-simulation/ -          Social Engineering Risk Assessments - https://www.social-engineer.com/offensive-security/social-engineering-risk-assessment/ -          Social-Engineer channel on SLACK - https://social-engineering-hq.slack.com/ssb -          CLUTCH - http://www.pro-rock.com/ -          innocentlivesfoundation.org - http://www.innocentlivesfoundation.org/                 03:47 - The Topic of the Day: Psychopathy 04:28 - A Proper Definition 06:13 - Key Indicators 07:46 - Lack of Empathy 09:36 - The Influence of Social Media 11:51 - Evil ≠ Psychopathy 12:40 - Environment Matters 14:17 - Size Matters 16:02 - MasterClass Ad 17:28 - Work Advantage 18:46 - Gender Differences 20:54 - Big Red Flag! 26:00 - Teaching Emotional Regulation 27:27 - Label Hoarding 32:33 - It's Not Exclusive 36:04 - Wrap Up 36:58 - Next Month's Topic: Imposter Syndrome 37:23 - Outro -          www.social-engineer.com -          www.innocentlivesfoundation.org   Find us online: -          LinkedIn: linkedin.com/in/dr-abbie-maroño-phd -          Instagram: @DoctorAbbieofficial -          LinkedIn: linkedin.com/in/christopherhadnagy     References: Blair, R. J. R. (2007). The amygdala and ventromedial prefrontal cortex in morality and psychopathy. Trends in Cognitive Sciences, 11(9), 387–392. https://doi.org/10.1016/j.tics.2007.07.003   Blair, R. J. R. (2013). The neurobiology of psychopathic traits in youths. Nature Reviews Neuroscience, 14(11), 786–799. https://doi.org/10.1038/nrn3577   Frick, P. J., & White, S. F. (2008). Research review: The importance of callous-unemotional traits for developmental models of aggressive and antisocial behavior. Journal of Child Psychology and Psychiatry, 49(4), 359–375. https://doi.org/10.1111/j.1469-7610.2007.01862.x   Glenn, A. L., & Raine, A. (2014). Neurocriminology: Implications for the punishment, prediction and prevention of criminal behaviour. Nature Reviews Neuroscience, 15(1), 54–63. https://doi.org/10.1038/nrn3640   Hare, R. D. (2003). Manual for the Hare Psychopathy Checklist–Revised (2nd ed.). Toronto, ON: Multi-Health Systems. Hare, R. D., & Neumann, C. S. (2008). Psychopathy as a clinical and empirical construct. Annual Review of Clinical Psychology, 4, 217–246. https://doi.org/10.1146/annurev.clinpsy.3.022806.091452   Patrick, C. J. (Ed.). (2018). Handbook of psychopathy (2nd ed.). New York, NY: Guilford Press. Pemment, J. (2013). Psychopathy versus sociopathy: Why the distinction has become crucial. Aggression and Violent Behavior, 18(5), 458–461. https://doi.org/10.1016/j.avb.2013.07.001   Severson, H., & Lynam, D. R. (2020). Psychopathy and antisocial personality disorder: Distinctions and implications for treatment. Current Opinion in Psychology, 37, 27–32. https://doi.org/10.1016/j.copsyc.2020.07.006   Skeem, J. L., Polaschek, D. L. L., Patrick, C. J., & Lilienfeld, S. O. (2011). Psychopathic personality: Bridging the gap between scientific evidence and public policy. Psychological Science in the Public Interest, 12(3), 95–162. https://doi.org/10.1177/1529100611426706   Viding, E., Blair, R. J. R., Moffitt, T. E., & Plomin, R. (2005). Evidence for substantial genetic risk for psychopathy in 7-year-olds. Journal of Child Psychology and Psychiatry, 46(6), 592–597. https://doi.org/10.1111/j.1469-7610.2004.00393.x   Walsh, Z., & Kosson, D. S. (2008). Psychopathy and violent crime: A prospective study of the influence of psychopathic traits on violence among offenders. Psychiatry, Psychology and Law, 15(2), 181–194. https://doi.org/10.1080/13218710802014489

Open yourself up with star pose ~ Star of Wonder (8 December 2011 - Toronto, ONT)

Nick Kypreos, Justin Bourne and Sam McKee look back on the Toronto Maple Leafs' loss to the New York Islanders. They discuss Auston Matthews surpassing Mats Sundin for the franchise record in goals, his legacy in Toronto, and what's behind his recent return to form. Then, they dive deeper into the game, another third-period blown lead, Matthew Schaefer's rising star, and the Leafs' options for a struggling Morgan Rielly. Later, they get into Joseph Woll's outing on Saturday, hear the latest from Craig Berube on the Leafs' long list of injuries, and outline the importance of the team's pre-Olympic break stretch.The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

Kazuma Okamoto to Toronto. Pirates fans are left staring at the same question: now what? On this episode of Bucco Brew, we break down the Blue Jays landing Kazuma Okamoto on a 4-year, $60 million deal and what it means for Pittsburgh after swinging big and coming up empty. With the “impact bat” still a need, where does the front office pivot if they want to be a real playoff contender in 2026? We dive into the latest buzz on Eugenio Suarez, including Jason Mackey's reporting that the Pirates have stayed in contact but may not have the winning bid, plus the realistic trade and free agent paths that could actually move the needle. Powered by De Fer Coffee & Tea. Use Promo Code NS930 for 30% off your first order at https://www.defer.coffee Use Promo Code NS9 for 30% off your first order at https://www.gritily.com Use Promo Code NORTHSHORENINE for $20 off your first order at https://www.seatgeek.com LIKE and SUBSCRIBE with NOTIFICATIONS ON if you enjoyed the show! NS9 MERCH: https://northshorenine.myshopify.com ►Patreon: https://www.patreon.com/NorthShoreNine ►Website: https://www.northshorenine.com ►Twitter: https://www.twitter.com/northshorenine ►TikTok: https://www.tiktok.com/@northshorenine ►Instagram: https://www.instagram.com/northshorenine ►Facebook: https://www.facebook.com/northshorenine ►Discord: https://discord.gg/3HVYPg544m Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Sportsnet's Ben Nicholson-Smith analyzes the Blue Jays signing of Japanese free-agent Kazuma Okamoto. Ben discusses if Okamoto can be an everyday third baseman, who the Jays may look to trade to manage positional needs, and how the Okamoto signing impacts the Jays chase for Kyle Tucker or Bo Bichette.  The show ends with 'What We Missed!' The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

JD reacts to Canada's semi-final loss at the World Juniors. Brady Quinn, NFL FOX analyst and former NFL quarterback, breaks down (10:00) the Pittsburgh Steelers dramatic win over the Baltimore Ravens, what may be in John Harbaugh's future, Kevin Stefanski's firing, the surging Seattle Seahawks, the surprising Carolina Panthers, and the bad look in college football. JD touches on Auston Matthews' passing Mats Sundin for the all-time Maple Leafs scoring record (47:00). The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

Meghan Markle has been labelled the most disappointing celebrity of 2025 by the Toronto Star, in a critical opinion piece arguing she had the ingredients for global success but “slowly deflated” over the past year. The article is notable given Meghan's long connection to Toronto during her years filming Suits and the city's significance in the early stages of her relationship with Prince Harry.Meanwhile, Star magazine claims tensions between Prince William and Prince Harry have flared again over Princess Diana's legacy, with a source suggesting Harry wants to pursue a screen project without William's involvement and would lean on existing Netflix relationships to do it. Rob Shuter also claims Meghan wants to direct, with one source describing her as “intensely hands-on.”We also review comments from communications professionals who say the Sussexes' staff turnover is unusually high and potentially damaging, warning that repeated departures have become a story in their own right and may make it harder to recruit top-tier advisers going forward.Palace Intrigue is your daily royal family podcast, diving deep into the modern-day drama, power struggles, and scandals shaping the future of the monarchy.Hear our new show "Crown and Controversy: Prince Andrew" here.Check out "Palace Intrigue Presents: King WIlliam" here.

Send us a textLaura breaks down why most designers do not have a pricing problem, they have a scope and structure problem. She walks through practical strategies to increase profitability at your current rates, including tightening and clarifying your scope, reclaiming billable hours you are already working, streamlining your process for efficiency, and shifting from selling hours to selling outcomes and expertise. She also walks you through a powerful breakdown of what your hourly rate actually has to cover and why 200 dollars an hour is not what you think it is once overhead, taxes, and business costs are accounted for.You will leave this episode with a clearer understanding of how to protect your fees, honour your time, and run your design business like a true CEO, without feeling guilty for charging appropriately or afraid of client pushback.In this episode, you will learn:Why “pricing correctly” is not always about raising your ratesHow loose scope and fuzzy boundaries quietly erode your profitSimple ways to clarify what is included, what is not, and when additional fees applyHow to reclaim billable hours you are already working but not charging forProcess shifts that make your existing pricing more profitableHow to position your expertise and the transformation you provide, not just your labourWhat your hourly rate really has to cover and why your take-home is a fraction of that numberThe most common mindset blocks designers face around pricing and how to reframe themA free way to support the show is by leaving a five star rating and review on Apple Podcasts. It helps more designers discover The Business of Beautiful Spaces and step into their role as confident, profitable CEOs.In just one focused hour, we'll dive into whatever you need most—pricing strategies, client management, attracting high-end clients or building repeat business. You'll get clarity, strategy, and expert advice based on my 27+ years of running a thriving, seven-figure design firm.This is your chance to get real answers to the questions you've been dying to ask—from someone who's actually been there.Book your session as you need it—no strings attached.Be sure to follow along on Instagram @thebusinessofbeautifulspaces + @thorntondesign to stay up to date on what we're talking about next week. If you love our podcast, please, please, please leave us a review. If you have any questions or topic ideas OR you wish to be a guest email us thebusinessofbeautifulspaces@gmail.com or find us on instagram @thebusinessofbeautifulspacesLaura Thornton is the principle designer of Thornton Design Inc, located in Kleinburg, ON. Since founding the company in 1999, Laura has been committed to creating a new kind of interior design experience for her clients. Thornton Design is an experienced team of creative talents, focused on curating beautiful residential and commercial spaces in the Toronto, Ontario area and beyond. Now sharing all the years of experience with other interior designers to create a world of collaboration and less competition. The Business of Beautiful Spaces I @thebusinessofbeautifulspacesThornton Design I @thorntondesign

In this episode an update, stories of intimate partner violence, and folks you should know about. I wanted to bookend the episode with a story of bravery and power. Please stick around til the end, you will want to know about Chris Bearchell. She rocks.  I'd like to thank Feedspot for alerting us to the amazing fact that Panic: queer True Crime is, for the second year, in the top ten most listened to queer true crime podcasts. Thanks to Feedspot and thanks to you for making it happen. Hugs! Fanny & Stella: A Wild, Wild Victorian Ride Ernest Boulton and Frederick Park were "respectable" Victorian gentlemen who found freedom onstage as Fanny and Stella. Their drag performances thrilled audiences across 1860s–70s England—until they brought their show into the streets. Their arrest and scandalous trial exposed the era's hypocrisy and crushed both love and ambition. Fanny, Stella, and their circle lived boldly in a world that punished authenticity, making them pioneers to be celebrated. 2025 Update: Justice for Jimmie 'Jay' Lee in the Ole Miss Murder Case After an 11–1 mistrial and the later discovery of Jimmie "Jay" Lee's body, Timothy Herrington Jr. took a plea deal for Lee's killing. The judge said Mississippi "got it right this time," yet the state still lacks LGBTQ+ protections or hate crime coverage. Both young men had promising futures ended by homophobia—a reminder that being gay isn't deadly, but hate is. Her Short, Brilliant Life Was Cut Short by Violence When Girlalala (LaLa) and her boyfriend, Shanoyd Whyte Jr., fought on November 14, 2025, tragedy struck. Whyte pulled a gun and killed LaLa, leaving the community in shock. Intimate partner violence is alarmingly high in the trans community—but help is available. If you or someone you know is in danger, please seek support. Timothy Smith Murder Trial Update Timothy Smith and Herbert Swilley seemed the picture of happiness in Ocala, Florida—until coworkers found Smith dead in March 2023. He'd been drugged, strangled, and left in a staged scene. Months later, Swilley was charged with first-degree premeditated murder. Warrior Chris Bearchell: "No More Sht" Christine "Chris" Bearchell was a fearless Canadian lesbian activist who helped reshape LGBTQ+ rights. From challenging sexist dress codes in high school to leading protests after Toronto's 1981 bathhouse raids, she fought back against police harassment and public shaming. A founder of the Canadian Lesbian and Gay Archives and key voice in securing Ontario's human rights protections, she also championed sex workers' rights and HIV/AIDS outreach. Bearchell died in 2007 at 53—remembered as a visionary warrior who deserves wider recognition. You deserve to live a life free of violence of any kind. DOMESTIC VIOLENCE INTIMATE PARTNER VIOLENCE National Hotlines and Support National Domestic Violence Hotline Phone: 1-800-799-SAFE (7233) Text: Text "START" to 88788 Live Chat & Information: thehotline.org   Services are available 24/7, confidential, and support all individuals regardless of identity or background.   Trans Lifeline: A trans-led hotline providing emotional support and crisis intervention for trans people.   Call 877-565-8860 or visit translifeline.org.​ The Network/La Red: A 24-hour confidential hotline for LGBTQ+ people experiencing domestic violence.   Call 617-742-4911 (local) or 800-832-1901 (toll-free).   If you or someone you know is in danger: Call 9-1-1 immediately. Please subscribe and share this story.   These stories deserve our loving attention.  

Episode 128 of Tablesetters is a mini reaction pod focused on a pivotal stretch of the offseason where one signing, one trade market, and one free agent begin to reshape how teams are positioning themselves for 2026. We open in Toronto, where the Blue Jays officially make their long-anticipated breakthrough in the Japanese market by signing Kazuma Okamoto to a four-year, $60 million contract just ahead of the expiration of his 45-day posting window. The deal is a straight four-year agreement with no opt-outs, structured as a $5 million signing bonus, a $7 million salary in 2026, and $16 million salaries in each of the final three seasons, with Okamoto represented by the Boras Corporation. To create a 40-man roster spot, Toronto designated right-hander Paxton Schultz for assignment. MLB Trade Rumors ranked Okamoto 19th on its top 50 free agents list and projected a four-year, $64 million deal, putting the final terms right in line with expectations. The signing also triggers a $10.875 million posting fee to the Yomiuri Giants under the NPB–MLB posting system. From there, we break down what Okamoto's arrival does to the Blue Jays' roster construction. The 29-year-old projects as Toronto's regular third baseman, while also bringing experience at first base and in the outfield. His versatility creates ripple effects across the lineup, including a likely platoon with Addison Barger at third base, more consistent second base work for Ernie Clement, and a positional shift that moves Andrés Giménez from second base to everyday shortstop. We also examine how the picture changes if Bo Bichette re-signs, and how crowded things could become if Toronto lands another rumored target like Kyle Tucker. The signing adds another layer to an offseason for a Blue Jays team that came within two outs of winning Game 7 of the World Series, following earlier pitching additions like Dylan Cease, Cody Ponce, and Tyler Rogers. It also effectively closes the door on pursuits of Alex Bregman and Yoán Moncada unless Toronto makes the unconventional decision to deploy Okamoto primarily in the outfield. Next, we shift to the trade market, where Edward Cabrera has emerged as one of the most consequential arms potentially available. The Yankees are actively engaged in discussions with the Marlins while also remaining involved on Freddy Peralta, with the Mets and Cubs also expressing interest in Cabrera. We break down why Cabrera's 2025 season, his power profile, his remaining club control through 2028, and his projected $3.7 million arbitration salary make him such an attractive target. We also examine the injury concerns that complicate his value, the Yankees' urgent rotation needs with Gerrit Cole and Carlos Rodón set to open the year on the injured list, and why Cabrera's affordability matters for both New York and Chicago as they juggle payroll, roster needs, and other offensive pursuits. For the Mets, we look at how their rotation has remained largely untouched despite major position-player turnover, and why their collection of young infield talent could factor into any serious push for pitching. We close with the expanding market for Cody Bellinger, as the Cubs check in and join a group that already includes the Yankees, Dodgers, Giants, Mets, Angels, Blue Jays, and Phillies at various points this offseason. We discuss why Chicago's interest reads as due diligence rather than a clear pivot, how Bellinger fits their roster, and why prospect timelines complicate any reunion. From there, we focus on the Yankees, where Bellinger remains the top offseason priority and negotiations have escalated to a second formal offer. We break down the roster logjam his return would create, how it impacts Jasson Domínguez and Spencer Jones, and why a Bellinger deal could directly intersect with New York's pursuit of Edward Cabrera. Steve and Devin connect the dots across international markets, trade leverage, payroll pressure, and roster math, focusing less on headlines and more on what these developments reveal about how teams believe they need to be built to win in 2026. ⚾️ One signing changes the board, trade talks gain momentum, and leverage begins to shift.

Margaret Atwood is a Canadian writer. She has published more than sixty books spanning novels, poetry, short stories, non-fiction, children's literature, and graphic novels, and has been called “one of the sharpest and most imaginative novelists writing in English”. She is one of only four writers to have won the Booker Prize twice: for The Blind Assassin in 2000 and for her 2019 follow-up to The Handmaid's Tale, The Testaments.Margaret was born in Ottawa in November 1939, shortly after the outbreak of World War II, the second of three children to Carl Atwood, an entomologist. During her early life, she would spend the warmer months in the remote forests of northern Quebec and Ontario where her father tracked insect infestations, and the winters in the city (first Ottawa, later Toronto). She didn't attend school for a full year until the age of twelve.Her childhood scribblings – a “novel” about an ant called Annie, a volume of rhyming poems about cats, and a play about a giant – turned into a more serious ambition to become a writer when Margaret was sixteen. After studying English at the University of Toronto, where she began publishing poems in the college magazine, her first novel, The Edible Woman, came out in 1969, following five collections of poetry. Her most famous work, The Handmaid's Tale, was published in 1985 and depicted a dystopian vision of the United States as a patriarchal and totalitarian place called Gilead. Although it was written during the Reagan era, it has become eerily relevant again in the wake of the election of Donald Trump. Margaret lost her life partner, the writer Graeme Gibson, in 2019. She lives in Toronto.DISC ONE: Anchors Aweigh - US Navy Band DISC TWO: Hearts of Stone - The Charms DISC THREE: Offenbach: Les contes d'Hoffmann, Giulietta Act: Barcarolle. Belle nuit, ô nuit d'amour. Performed by Joan Sutherland (soprano) Huguette Tourangeau (soprano), Plácido Domingo (tenor), Andre Neury (bass), Pro Arte Choir, Lausanne, Choeur Du Brassus, Choeur de la Radio Suisse Romande, Orchestre de la Suisse Romande, conducted by Richard Bonynge DISC FOUR: Four Strong Winds - Ian & Sylvia DISC FIVE: Barrett's Privateers - Stan Rogers DISC SIX: The Handmaid's Tale, Act I Scene 6: The Doctor. Composed by Poul Ruders and performed by Marianne Rorholm, Hanne Fischer (Mezzo-sopranos), Royal Danish Opera Chorus and Royal Danish Orchestra, conducted by Michael Schønwandt DISC SEVEN: We Praise the Tiny Perfect Moles - Orville Stoeber DISC EIGHT: Symphony No. 6 in F Major, Op. 68 "Pastoral": II. Scene am Bach. Andante molto moto. Composed by Beethoven and performed by Philharmonia Orchestra, conducted by Otto Klemperer BOOK CHOICE: How to Survive on a Desert Island by Samantha Bell LUXURY ITEM: A knife and matchbox CASTAWAY'S FAVOURITE: Hearts of Stone - The Charms Presenter: Lauren Laverne Producer: Sarah Taylor

Louise Penny is one of the biggest mystery novelists alive today … but it didn't start out that way. Her latest novel, The Black Wolf, is the 20th in her bestselling Armand Gamache series. So how did Louise go from empty book events to packed concert halls? This week, Bookends brings you on-stage at Toronto's historic Massey Hall. Joined by nearly 2000 of her fans, Louise told Mattea Roach about her long journey to becoming an author, why she'll never tire of her characters and how pain has made her a better writer. Liked this conversation? Keep listening:Chris Hadfield — from astronaut to author Kiran Desai's novel is worth the 20-year wait

Watch all of our Kevin A videos here:    • Kevin A  Kevin's links: EMAIL KEVIN hiddenfromhistory1@gmail.com Listen to Kevin and the Voice of the Republic live every Sunday at 6 pm eastern at www.bbsradio.com/herewestand The website of the Republic is www.republicofkanata.org See the evidence www.murderbydecree.com Videos: Kevin A Filmed in Toronto at That Channel TV studio in the spring of 2019    • Kevin Annett - A Candid Interview On The C...    and    • KEVIN ANNETT AND CANADA'S GENOCIDE FULL LE...  Kevin's book: by Decree https://www.amazon.com/dp/1530145619 Kevin on Telegram: t.me/murderbydecree Watch Zachary King Part 1 https://youtube.com/live/oEMnuj-V4X4 Watch MK ULTRA TUNNELS SURVIVOR    • MK ULTRA TUNNELS SURVIVOR - Annalie Cummin...  Shaun Attwood's social media: TikTok:   / shaunattwood1    / shaunattwood  Twitter:   / shaunattwood  Facebook:   / shaunattwood1  Patreon:   / shaunattwood  Odysee: https://odysee.com/@ShaunAttwood:a #popefrancis #pope #news #world #vatican #catholic #catholicchurch #popeleoxiv #USA

The list of people Donald Trump has punished or threatened to punish since returning to office is long. It includes the likes of James Comey, Letitia James, John Bolton, as well as members of the opposition, such as Adam Schiff, Mark Kelly and Kamala Harris.In fact, he has gone so far as to call Democrats “the enemy from within”, saying they are more dangerous than US adversaries like Russia and China.According to Lucan Way, a professor of democracy at the University of Toronto, when a leader attacks the opposition like this, it's a clear sign a country is slipping into authoritarianism.As Way says in episode 5 of The Making of an Autocrat:"In other kind of countries with weaker justice systems, you can literally jail members of opposition or bankrupt them. In a country like the United States, where the rule of law is quite robust, this is not possible, you can't just jail rivals at will."But Trump has other ways of making the cost of opposing him too high for his critics to bear. This includes investigations, lawsuits, audits, personal attacks – anything to distract and silence them.The effect is his opponents become much more reluctant to engage in behaviour they know that Trump won't like, Way says:"So it really has this kind of broader silencing effect that I think is quite pernicious."This episode was written by Justin Bergman and produced and edited by Isabella Podwinski and Ashlynne McGhee. Sound design by Michelle Macklem.

Tim and Chris break down the Hawks' big 111–99 win over the Knicks, highlighted by a standout night from Onyeka Okongwu. With Trae Young sidelined, Okongwu stepped up in a major way—finishing with 23 points and 9 rebounds, knocking down a pair of timely threes, and bringing nonstop energy on both ends of the floor. The guys also hand out their 3 Keys for the Hawks to secure another win on the second night of a back-to-back as they head to Toronto tomorrow night. FOLLOW us on “X”: @EthosHawks @Tim_ATL @MRKHoops The FantasyPass isn't just for drafts anymore! Come enjoy DAN'S FANTASY ADDS/DROPS IN REAL TIME in our premium Discord… starting at just $6/month! Click to learn more! SUBSCRIBE, Rate and Review iTunes: https://tinyurl.com/ymf6vssp Spotify: https://tinyurl.com/yll6somy Join our Fantasy Sports Discord Server by clicking this sentence – https://discord.gg/jSwGWSHqaV Looking for the Bru and Besbris Secret Shows? The only way to get the URLs when they happen is to jump on the email list by heading here: https://landing.mailerlite.com/webforms/landing/g5c9a0 Manscaped is BACK, baby! Just like the NBA! Use coupon code HOOPBALL20 to get 20% off and free shipping on your purchase at Manscaped.com! Want more codes? We got 'em! ExpressVPN is offering 3 BONUS months on every 12-month membership purchase by using this special link: https://www.expressvpn.com/hoopball Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.